Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 31;10(4):e0171422.
doi: 10.1128/spectrum.01714-22. Epub 2022 Aug 8.

Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients

Affiliations

Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients

Nils Wetzstein et al. Microbiol Spectr. .

Abstract

Infections due to Mycobacterium abscessus are a major cause of mortality and morbidity in cystic fibrosis (CF) patients. Furthermore, M. abscessus has been suspected to be involved in person-to-person transmissions. In 2016, dominant global clonal complexes (DCCs) that occur worldwide among CF patients have been described. To elucidate the epidemiological situation of M. abscessus among CF patients in Germany and to put these data into a global context, we performed whole-genome sequencing of a set of 154 M. abscessus isolates from 123 German patients treated in 14 CF centers. We used MTBseq pipeline to identify clusters of closely related isolates and correlate those with global findings. Genotypic drug susceptibility for macrolides and aminoglycosides was assessed by characterization of the erm(41), rrl, and rrs genes. By this approach, we could identify representatives of all major DCCs (Absc 1, Absc 2, and Mass 1) in our cohort. Intrapersonal isolates showed higher genetic relatedness than interpersonal isolates (median 3 SNPs versus 16 SNPs; P < 0.001). We further identified four clusters with German patients from same centers clustering with less than 25 SNPs distance (range 3 to 18 SNPs) but did not find any hint for in-hospital person-to-person transmission. This is the largest study investigating phylogenetic relations of M. abscessus isolates in Germany. We identified representatives of all reported DCCs but evidence for nosocomial transmission remained inconclusive. Thus, the occurrence of genetically closely related isolates of M. abscessus has to be interpreted with care, as a direct interhuman transmission cannot be directly deduced. IMPORTANCE Mycobacterium abscessus is a major respiratory pathogen in cystic fibrosis (CF) patients. Recently it has been shown that dominant global clonal complexes (DCCs) have spread worldwide among CF patients. This study investigated the epidemiological situation of M. abscessus among CF patients in Germany by performing whole-genome sequencing (WGS) of a set of 154 M. abscessus from 123 German patients treated in 14 CF centers. This is the largest study investigating the phylogenetic relationship of M. abscessus CF isolates in Germany.

Keywords: German CF registry; Mycobacterium abscessus; cystic fibrosis; dominant circulating clones; hospital transmission; nontuberculous mycobacteria; whole-genome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare a conflict of interest. N. Wetzstein has nothing to disclose. M. Diricks reports institutional funding (Research Center Borstel) from the German Research Foundation (DFG) under Germanys Excellence Strategy EXC 2167 (Precision Medicine in Inflammation), the Leibniz Science Campus Evolutionary Medicine of the LUNG (EvoLUNG), and the German Center for Infection Research (DZIF). T. A. Kohl has nothing to disclose. T. A. Wichelhaus reports research grants from MSD and Deutsche Krebshilfe, honoraria for lectures and consulting from Insmed and Osartis. S. Andres has nothing to disclose. L. Paulowski has nothing to disclose. C. Schwarz reports grants from Vertex Pharamaceuticals and the German Mykoviszidose Institut gGmbH and the German Federal Ministry of Health, honoraria for lectures and presentations from Vertex Pharamaceuticals, Chiesi GmbH and AbbVie Deutschland. A. Lewin has nothing to disclose. J. Kehrman has nothing to disclose. B. C. Kahl reports honoraria for lectures and presentations and supports for attending meetings and/or travel from Pfizer Germany. K. Dichtl has nothing to disclose. C. Hügel reports Grants from the German Mykoviszidose Institut gGmbH. O. Eickmeier has nothing to disclose. C. Smaczny has nothing to disclose. A. Schmidt has nothing to disclose. S. Zimmerman reports Grants from Bosch HealthCare Systems and on the MSD Investigator-initiated grant PNEU-MISP. L. Nährlich reports institutional fees for study participation by the German Center for Lung Research; Vertex Pharamaceuticals and Boehringer Ingelheim; participation Trial Steering Committee for CF STORM and duties as Medical lead of the German CF-registry and Pharmacovigilance study manager of the ECFSPR. S. Hafkemeyer has nothing to disclose. S. Niemann reports grants from the German Research Foundation (DFG) under the Excellence Cluster EXC 2167 (Precision Medicine in Inflammation) and the Leibniz Science Campus Evolutionary Medicine of the LUNG (EvoLUNG). F. P. Maurer reports grants from Mukoviszidose Institut gGmbH, Bonn and the German Federal Ministry of Health. M. Hogardt reports grants from Mukoviszidose Institut gGmbH and the German Federal Ministry of Health, honoraria for lectures from the Landesärztekammer Hessen and bioMérieux, and funding from Merck AG outside the submitted work.

Figures

FIG 1
FIG 1
(A) Total number of tested CF-patients, negative and positive NTM results from 2015 to 2020 as reported in the German CF registry. (B) Species and age distribution of patients with positive NTM cultures (raw data are not shown). (C) Subspecies distribution for M. abscessus as reported in the German CF registry, 2015 to 2020.
FIG 2
FIG 2
(A) Geographic provenance and subspecies distribution of sequenced CF patient isolates included in this study. (B) Collection date and subspecies distribution of included M. abscessus isolates (n = 154).
FIG 3
FIG 3
Phylogenetic tree based on whole-genome SNPs in German (n = 154) and international (n = 55) isolates included in the study. Isolate characteristics (subspecies, CF versus Non-CF, country of origin, and genotypic resistance markers (erm(41), rrl, rrs) are indicated by color code). The reference strains M. abscessus subsp. abscessus ATCC 19977, M. abscessus subsp. massiliense JCM15300, and M. abscessus subsp. bolletii JCM15297 are indicated by circles in the respective colors of the subspecies.
FIG 4
FIG 4
(A) Flowchart of included isolates in cluster analyses (n refers to the respective number of isolates.). (B) SNP distances for four different types of d25 clusters. (C) SNP distances in ‘same center’ clusters, including patients treated at the same German CF center.

References

    1. Martiniano SL, Nick JA, Daley CL. 2016. Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med 37:83–96. doi:10.1016/j.ccm.2015.11.001. - DOI - PubMed
    1. Schnabel D, Gaines J, Nguyen DB, Esposito DH, Ridpath A, Yacisin K, Poy JA, Mullins J, Burns R, Lijewski V, McElroy NP, Ahmad N, Harrison C, Parinelli EJ, Beaudoin AL, Posivak-Khouly L, Pritchard S, Jensen BJ, Toney NC, Moulton-Meissner HA, Nyangoma EN, Barry AM, Feldman KA, Blythe D, Perz JF, Morgan OW, Kozarsky P, Brunette GW, Sotir M, Centers for Disease Control and Prevention (CDC) . 2014. Notes from the field: rapidly growing nontuberculous Mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic–multiple states, March 2013–February 2014. MMWR Morb Mortal Wkly Rep 63:201–202. http://www.ncbi.nlm.nih.gov/pubmed/24598597 - PMC - PubMed
    1. Bonaiti G, Pesci A, Marruchella A, Lapadula G, Gori A, Aliberti S. 2015. Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis. Biomed Res Int 2015:1–8. doi:10.1155/2015/197950. - DOI - PMC - PubMed
    1. Esther CR, Esserman DA, Gilligan P, Kerr A, Noone PG, Noone PG. 2010. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 9:117–123. doi:10.1016/j.jcf.2009.12.001. - DOI - PMC - PubMed
    1. Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. 2019. Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients. Int J Mol Sci 20:5868. doi:10.3390/IJMS20235868. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources